accountMedivation (MDVN) is expected to release the results of its Phase 3 clinical trial of Dimebon in the not to distant future. Dimebon is designed for the treatment of Alzheimer's disease.....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Is Pfizer Medivation's Dimebon a $1.5 Billion Blockbuster Drug ?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account